{"name":"Juniper Pharmaceuticals, Inc.","slug":"juniper-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"COL-1077","genericName":"COL-1077","slug":"col-1077","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"COL-1077","genericName":"COL-1077","slug":"col-1077","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-04","type":"pipeline","source":"BusinessLine","summary":"30 stocks to watch: Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla - BusinessLine","headline":"30 stocks to watch: Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOdWktdnJtbG9xcExoemZjMXAtNF8zRDV1ZklwX0VFMHVLcGVZaEVCYU05N09iMGg3VTBxMTR4SkVNeFNLWWgyVVZ6dkZ4STFuVFVvb05kV01ZaW82TXRqUXdrc0hNNFRtdFY1TTNzXzFzOTNmWTIxU2RvUjEzdW81S0tTeTAxYjB3dUY4bGJmRl9vYjA0ZlI2S2hhd2RsQWEzTy1FWGtNMGtENTJaaWI4?oc=5","date":"2026-02-12","type":"pipeline","source":"The Globe and Mail","summary":"Dozens of online-pharmacy ads, including for weight-loss drugs, appear to violate federal rules - The Globe and Mail","headline":"Dozens of online-pharmacy ads, including for weight-loss drugs, appear to violate federal rules","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVjA5ZWJjdGp2SlllLWpPWXlOQk5DNU9ZVW9Kd0htYlpxS1VWQV9sazI0eTFiZGZ3d3BRME9TMmRnMnJEcDVZd3g4UmZYVTl1OFdpdlZIZmxNLW0tV3ZLMEp0N2pidi1GWmViNENHVlkyb2lsWFdGMXlpaHZYd05Hb0RhQnZCRmlORjk2YUNRU01BbEJNc0xnSm1MWHJDN0VDZFNIS1IyVmxXd3VnZVRxUXFjVWt5Q3RoT0xqcDJONmktNmlZenhCdGNKRl9UR1pJdTdELUl0QXozUQ?oc=5","date":"2025-12-02","type":"pipeline","source":"Quiver Quantitative","summary":"Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon - Quiver Quantitative","headline":"Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5aVnFFckVGZXFRNldBZ1JTRWZKYUhNWFQxcWdlaGRUeEw1X1Q2WlZIbFpVc0dGTXE1VXFjVTZXUXV6VlVoWnZuTVR4VkdES2dsSkJtNHRSRjlkSlh5TTVTbWxucnJoY1BnY2o4Zmln?oc=5","date":"2022-04-13","type":"deal","source":"KED Global","summary":"Kolon Life inks technology transfer deal with Juniper Biologics - KED Global","headline":"Kolon Life inks technology transfer deal with Juniper Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBFUXZTSnBvSi04dng0cGxmVkdFODRQMHNvUHVLTDdNTEh0VUxRaFI4RHRTd21RYkVxWGk0S2YzdTZwTGpwV2EyNllSWEFKZHFmQWFjd3RhZkpmbzM4WEJ6ODhBWjF2NUthZ3lXZDRBTUVXNXBjZTVHa3JlVzA?oc=5","date":"2018-08-20","type":"deal","source":"PharmTech.com","summary":"Catalent Acquires Juniper Pharmaceuticals - PharmTech.com","headline":"Catalent Acquires Juniper Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNektfb2tvMGE3eVQ5NXJldEV4cGoxYUxJVGdtY01OeVlTSTVBXzBWS2xjMy1GOVRrUy1vYmNkNTVjV3lzM2EtY2ZCbkZBVHB5NWExX0oxWXhSd0pvcl81NExvR1c2QUktMFR3Nm1MWGJZb2luSWttemZTZnlNOFFJSzU1Mkhpdm8tN1ZJcGQzMXg2SnM?oc=5","date":"2018-08-15","type":"pipeline","source":"BioPharma Dive","summary":"Catalent completes $130M acquisition of Juniper - BioPharma Dive","headline":"Catalent completes $130M acquisition of Juniper","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOajJMaGlhdGxJNFlFdXg3VklNWnp3WlZuNW5FcUd2ak9iTC1DRTRtblVfbHgtRXA0dDNuNkdNT3VOc29KbU8xV2RfMjRRU25hUngtVUx2ZXlEZmZ0QjlPajA2TFUxYUd6MVRlN0lfZFJ5UWFlSzdERFFIeW53NW41dXhWaXR6QVdNYnFtRQ?oc=5","date":"2018-08-14","type":"pipeline","source":"Contract Pharma","summary":"Catalent Completes Juniper Acquisition - Contract Pharma","headline":"Catalent Completes Juniper Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYzRTaF9UUVR2VjNVaXNBMnVTMEVCSzF0Y2RuYTZ6T2Ryc2VwMnVWTkJ2bk41X01ybE1vdVM5aUN4ZjRCZWZIcUZHRktTUnJKVUQwRVo4aXhGOG5MZlZmOFVkZEsxVFlaYXROdTV5VmJySkNweFVBeThzdzVmalZMTXBMN040OEk2VkYtQjlkNE1STk96ZENBWThQVXZiT1ZCZVZyNGdGNTQzX2ZIUG1ic21UT1Vqd2ExYW9sRVZBVHlLd0R6RkNjaGZEV0hWWmt4cDd4QThSRVRHYm12NXcxczYtMjJNUFlVbU1ZOV9HSFVDOGg2SUlhcA?oc=5","date":"2018-07-03","type":"deal","source":"prnewswire.com","summary":"Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash - prnewswire.com","headline":"Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNdDAwQ0Y5bzZ5a1ZhZ09MdnpFX0Q4S2owN183RlU3VkFLR2tQdGM1SnFvcGk1dXdtVEZCaFBVZ1B6b1NXWkkxWm5Ebkl4a3JKaUtJWnhVNXBORHVGZTNBNnRMTml2a2JNalU2RXBWd0s3ZWo1ajRVTS1WYUM0aEFFOE5Kcjg5T0toUnN2eVZEdzNmMEJNSEx1UmxPTk5zNmpSUDV3UQ?oc=5","date":"2018-07-03","type":"deal","source":"ROI-NJ","summary":"Catalent to acquire Juniper Pharma in $133M deal - ROI-NJ","headline":"Catalent to acquire Juniper Pharma in $133M deal - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNOGpWcjQxSGFJSVQ4RzhSY3Q2am5IQjh3ZTFnSDBsWi1oWi1ZcTdHSlhKcmdDZ1JtZ3FaT2E0dWlwa010RUR4UTRsV0xkUHZ0ck1jRUI4akJtMXlIR1pmUEw1MnN2V0E0QWNhRGNrR1VVVFZ0THduel9HeU0taTVUQ0tPclgyYUxNcVBBOVBYQmlyM0ZkejdPVXNUQXpVblRMaWxXWVBjMmtLdnpyNnNlaG1Ib2RWRnl6dXRxa2QyRk0yV0NGaTdiaEZWRUhnT3NzNTJmb0xB?oc=5","date":"2017-12-29","type":"pipeline","source":"prnewswire.com","summary":"Juniper Pharma Services' co-founder awarded CBE in the Queen's New Year's Honours List - prnewswire.com","headline":"Juniper Pharma Services' co-founder awarded CBE in the Queen's New Year's Honours List","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQdzRBdUQ0ejJWVVB5MHhfQktyRnhWdHo5bDlfZmJGbkVqSFhLMUNQSm5XZ0YwUkRRWS1OQXo0dXBsVXYzakUwakxESXZmSmdLNUNBTUxUdk4xQUd6ZzFBbUJ3UUZlUVR3d2EzWEEwRzJza0lTaTh0aHFxNm1BalozVlVSY1poVERZZVRqV1o2ZHlmaXJKc1E?oc=5","date":"2015-11-13","type":"pipeline","source":"BioSpace","summary":"Juniper Pharma Adds Three New Products To Its Proprietary Pipeline - BioSpace","headline":"Juniper Pharma Adds Three New Products To Its Proprietary Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOT05MOVo4QzEySW9oVU9RUTFQbmg0UXhuaFl2QjBGdU9CdTY2Zi0tSm5Ha0RvRnpHR2JUYWwtTmpHbXdYS0NVRGM4NE91WEpCSFc3dFZlemo1YTE5T0VROWhoMTM2eC1QZmhza2J1S2E0U05pRFhpdzl1bmk5NUVBZTd3ektqUjk4amtYVWRPM3l4alg1WUFRNFRCaE5QOEg5WDRMdlUwa3hfeU1Za1pNTEtn?oc=5","date":"2015-04-02","type":"pipeline","source":"Contract Pharma","summary":"Columbia Laboratories to Adopt Juniper Pharmaceuticals Brand Marks - Contract Pharma","headline":"Columbia Laboratories to Adopt Juniper Pharmaceuticals Brand Marks","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":8,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}